E-Brochure - Download Now!
If your fertility doctor has mentioned PGD or PGS, chances are you have already searched for the difference and come away more confused than before. The two names sound almost identical, the abbreviations keep changing, and some clinics now use entirely different letters, such as PGT-A and PGT-M.
Underneath the alphabet soup, though, the idea is simple: both tests examine the genetic characteristics of an embryo before it is transferred to the uterus. What differs is the question each test is designed to answer, and that matters when deciding whether testing is appropriate for your IVF journey.
Preimplantation genetic diagnosis, or PGD, is the older term associated with testing embryos for a specific inherited genetic condition or a known structural chromosome rearrangement. These tests are now generally called PGT-M and PGT-SR, respectively.
Preimplantation genetic screening, or PGS, is the older term for PGT-A. This test assesses whether an embryo has the expected number of chromosomes. Chromosome-number differences can affect implantation and increase the risk of miscarriage, although PGT-A does not guarantee pregnancy or a healthy baby.
| Feature | PGD (PGT-M / PGT-SR) | PGS (PGT-A) |
|---|---|---|
| What it checks | A specific inherited gene condition or structural chromosome rearrangement | Whether an embryo has the expected number of chromosomes |
| The question it answers | Does this embryo have the specific genetic condition or chromosome risk being tested? | Does this embryo show the expected chromosome number? |
| Who it may be for | Couples with a known inherited condition or a parent who carries a chromosome rearrangement | Patients considering chromosome screening as part of an individualised IVF plan |
| What it does not tell you | Other genetic conditions or chromosome-number differences unless these are tested separately | Whether an embryo is free of all genetic conditions or will result in a healthy baby |
| Key consideration | Can help reduce the risk of passing on a specific known genetic condition | Benefits vary by patient; routine use for every IVF patient has not been established |
Imagine each embryo as a book. PGT-A checks whether the book has the expected number of chapters, not too many and not too few. PGT-M looks for one specific misprint, a known genetic change that runs in the family. PGT-SR checks for structural chromosome rearrangements that may result in missing or duplicated chromosome material.
This is why the tests are not interchangeable. PGT-A does not test for a specific single-gene condition, while PGT-M does not automatically assess the overall number of chromosomes. If more than one genetic concern is relevant, your fertility specialist and genetic laboratory can explain which tests may be appropriate together.
These tests may be considered when:
PGT-A may be discussed as part of an individualised IVF plan, including for patients who:
These circumstances do not automatically mean that testing is necessary or will improve the chance of a live birth. Your specialist can explain the potential benefits, limitations, costs and alternatives for your specific situation.
Before agreeing to embryo testing, consider asking your fertility specialist a few direct questions:
Clear answers can help you understand whether testing fits your treatment plan. If the decision feels overwhelming, fertility counselling may also help you explore your concerns and options.
PGD and PGS are older terms for different types of embryo testing. PGT-M looks for a specific inherited genetic condition, PGT-SR examines structural chromosome rearrangements, and PGT-A assesses chromosome number. Understanding these distinctions can help you have a more informed discussion with your fertility specialist about whether testing belongs in your treatment plan.
Goral Gandhi, a clinical embryologist with over 25 years of experience in IVF, offers guidance on genetic testing options in Mumbai. Understanding the purpose and limitations of each test can help you make a decision suited to your circumstances.
Have questions about genetic testing before embryo transfer? Book a consultation to discuss your options with the fertility team.
Yes. PGS is the older name for PGT-A, which assesses the number of chromosomes in an embryo. PGD is an older umbrella term associated with tests now generally called PGT-M and PGT-SR, which examine specific genetic conditions and structural chromosome rearrangements.
No. PGT-A assesses chromosome number in the sampled embryo cells. It cannot rule out every genetic condition, birth defect or future health problem, and it does not guarantee implantation, pregnancy or a live birth. Your specialist can explain the test's limitations and whether other screening or diagnostic tests may be appropriate.
A mosaic embryo result means that testing has detected a mixture of cells with different chromosome findings in the sample. The result may not represent every cell in the embryo. The implications for pregnancy vary, and the evidence has limitations. A fertility specialist and genetic counsellor can help explain the findings and discuss possible options before a transfer decision is made.